The PI uptake was inhibited at 11.7% ± 0.1, 7.75 ± 2.7, and 13.9 ± 1.4 rates respectively after the GBM cell lines were pretreated 1 h with an inhibitor of necroptosis marker MLKL, NSA at 5 μM (Fig. 3B). This evidence concerns the gene MLKL and glioblastoma.